PharmiWeb.com - Global Pharma News & Resources

Clinical trials - Press Releases

Date Title Company
21-Sep-2023 Leucid Bio Granted MHRA Clinical Trial Authorisation for Lateral NKG2D CAR-T Cell Therapy LEU011 Leucid Bio
21-Sep-2023 CellProthera completes enrollment in Phase I/IIB trial for post-myocardial infarction cell therapy CellProthera
21-Sep-2023 SpyBiotech Announces MHRA Clinical Trial Application Filing for SPYVLP01 SpyBiotech
19-Sep-2023 Mural Health Raises $8M Led by Bessemer Venture Partners to Accelerate Growth Mural Health
19-Sep-2023 Biofourmis Accelerates and Simplifies Drug Development with Expanded Digital Clinical Trials Solution Biofourmis
19-Sep-2023 Over 50’s back auto-enrolment in clinical trials tackling long-term health conditions Lindus Health
19-Sep-2023 Panthera bucks the trend and brings vaccine trials to the UK Panthera Biopartners
19-Sep-2023 ImmunOs Therapeutics Appoints Dr. Constanze Guenther as Senior Vice President, CMC and Technical Development ImmunOs Therapeutics
19-Sep-2023 1ST Biotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with MSD to Evaluate FB849 in Combination With KEYTRUDA® (pembrolizumab) 1ST Biotherapeutics, Inc.
19-Sep-2023 Thermosome Establishes High-Profile Clinical Advisory Board Thermosome GmbH
15-Sep-2023 Positive results from the Phase II study of uTRACE in brain cancer presented at the World Molecular Imaging Congress (WMIC) 2023 in Prague Curasight A/S
14-Sep-2023 MODERNA EXPANDS THE FIELD OF MRNA MEDICINE WITH POSITIVE CLINICAL RESULTS ACROSS CANCER, RARE DISEASE, AND INFECTIOUS DISEASE Moderna
14-Sep-2023 Moderna Expands the Field of mRNA Medicine with Positive Clinical Results Across Cancer, Rare Disease, and Infectious Disease Moderna
14-Sep-2023 Lundbeck presents clinical advances in migraine prevention with positive trial results at international headache congress H. Lundbeck A/S
14-Sep-2023 Curia Supports Replicate Bioscience’s Phase 1 Clinical Trial of Novel Next-Generation RNA Vaccine Curia
13-Sep-2023 Invitation to learn from the best: Evening of insights and networking will honor a clinical data management stalwart Phastar
13-Sep-2023 AbbVie's SKYRIZI® (risankizumab) Met All Primary and Secondary Endpoints Versus Stelara® (ustekinumab) in Head-to-Head Study in Crohn's Disease AbbVie
12-Sep-2023 Fasenra met the primary endpoint in the MANDARA Phase III trial in eosinophilic granulomatosis with polyangiitis (EGPA) AstraZeneca
12-Sep-2023 HUTCHMED Highlights Presentation of Results from the Phase IIIb Trial of Savolitinib at the 2023 World Conference of Lung Cancer HUTCHMED
12-Sep-2023 AlgoTx Announces First Patients Dosed in US and European Arms of Phase II Clinical Trial of ATX01 in Rare Disease Erythromelalgia AlgoTherapeutix (AlgoTx)